Plasmonic Laser Ablation Device Market Expected to Grow at 10.2% CAGR Through 2029: Industry Forecast

on

Plasmonic Laser Ablation Device Market
 
Get 20% Off Market Intelligence Reports With Code ONLINE20 – Track Global Tariffs, Economic Shifts, and Sector Transformations


What Is the Plasmonic Laser Ablation Device Market Growth Potential Across Different Regions?
The plasmonic laser ablation device market size has grown rapidly in recent years. It will grow from $1.35 billion in 2024 to $1.50 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to rising prevalence of cancer and chronic diseases, growing investment in medical research and clinical trials, rising integration of plasmonic in biomedical applications, growing adoption in material science and nanotechnology and increasing focus on patient safety and recovery.

The plasmonic laser ablation device market size is expected to see rapid growth in the next few years. It will grow to $2.21 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing use of femtosecond and nanosecond laser pulses, rising demand for outpatient and day-care surgeries, growing trend of precision medicine, increasing adoption in dermatological and cosmetic procedures and growing demand for image-guided surgical technologies. Major trends in the forecast period include advancements in femtosecond and nanosecond laser technologies, integration of real-time imaging systems, developments in biocompatible nanoparticle formulations, advancements in surface plasmon resonance (SPR) monitoring and developments in photothermal and photomechanical effects.

Claim your free report sample now:

What Are the Top Drivers and Growth Contributors in the Plasmonic Laser Ablation Device Market?
The increasing demand for minimally invasive procedures is expected to drive the growth of the plasmonic laser ablation device market in the future. Minimally invasive procedures are medical techniques performed through small incisions or natural openings using specialized tools to reduce pain, scarring, and recovery time. Minimally invasive procedures are increasing due to their faster recovery times, allowing patients to return to normal activities more quickly with fewer complications. Plasmonic laser ablation devices are utilized in minimally invasive procedures for highly precise and localized tissue removal, resulting in minimal thermal damage to surrounding areas. This approach reduces incision size and accelerates healing. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based professional society, nearly 25.4 million minimally invasive procedures were performed in 2023, an increase of 7% from 2022. Therefore, increasing demand for minimally invasive procedures is driving the growth of the plasmonic laser ablation device market.

Rising Healthcare Expenditure Drives Growth Of The Market Due To Increasing Demand For Advanced And Cost-Effective Treatment Solutions

The rising healthcare expenditure is expected to propel the growth of the plasmonic laser ablation device market going forward. Healthcare expenditure refers to the total spending on medical services, treatments, and health-related resources by individuals, governments, and organizations. Healthcare expenditure is increasing due to the aging population, as older individuals typically require more frequent and costly medical care for chronic conditions and age-related illnesses. Increasing healthcare expenditure supports the development and adoption of advanced technologies such as plasmonic laser ablation devices by providing funding for research, procurement, and integration into clinical practice. For instance, in March 2022, according to the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, the annual increase in national health spending was predicted to average 5.1% between 2021 and 2030, reaching approximately $6.8 trillion by 2030. Therefore, the rising healthcare expenditures are driving the growth of the plasmonic laser ablation device market.

Rising Clinical Trials Drive Growth Of The Market Due To Increasing Demand For Personalized Medicine

The increasing clinical trials are expected to propel the growth of the plasmonic laser ablation device market going forward. Clinical trials refer to research studies involving human participants that are conducted to evaluate the safety, effectiveness, and outcomes of medical treatments or interventions. Clinical trials are increasing due to the growing demand for personalized medicine, requiring testing of tailored treatments on specific patient populations to ensure optimal outcomes. Plasmonic laser ablation devices assist in clinical trials by providing high-precision cellular or molecular analysis, allowing researchers to study disease mechanisms and treatment effects more effectively. For instance, in November 2023, according to the Association of the British Pharmaceutical Industry, a London-based trade association, an annual recruitment for industry clinical trials in the UK rose by 15%, increasing from 36,722 participants in 2021/22 to 42,088 in 2022/23. Therefore, the increasing clinical trials are driving the growth of the plasmonic laser ablation device market.

What Are the Major Product/Service Segments in the Plasmonic Laser Ablation Device Market?
The plasmonic laser ablation device market covered in this report is segmented

1) By Type: Yttrium Aluminum Garnet Laser, Carbon Dioxide Laser, Other Types
2) By Device Type: Pulsed Plasmonic Laser Ablation Devices, Continuous Wave Plasmonic Laser Ablation Devices, Femtosecond Plasmonic Laser Ablation Devices, Nanosecond Plasmonic Laser Ablation Devices
3) By Technology: Surface Plasmon Resonance (SPR) Technology, Nanoparticle Mediated Laser Ablation, Optical Coherence Tomography (OCT)
4) By Application: Medical Applications, Material Processing, Research And Development
5) By End-User: Hospitals, Research Institutes, Manufacturing Industries, Other Users

Subsegments:
1) By Yttrium Aluminum Garnet: Nanosecond Yttrium Aluminum Garnet Laser, Picosecond Yttrium Aluminum Garnet Laser, Q-switched Yttrium Aluminum Garnet Laser
2) By Carbon Dioxide (CO2) Laser: Continuous Wave Carbon Dioxide Laser, Pulsed Carbon Dioxide Laser, rational Carbon Dioxide Laser
3) By Other Types: Femtosecond Laser, Excimer Laser, Ultrafast Laser




Who Are the Industry Leaders in the Plasmonic Laser Ablation Device Market?
Major companies operating in the plasmonic laser ablation device market are Mitsubishi Electric Corporation, Boston Scientific Corporation, Trumpf Group, Coherent Corp., Han’s Laser Technology Industry Group Co. Ltd., Lumentum Holdings Inc., Thorlabs Inc., Edmund Optics Inc, Jenoptik AG, Universal Laser Systems Inc., Cincinnati Incorporated, Epilog Laser, RPMC Lasers, Dongguan Mactron Technology Co. Ltd., Aesthetic World, Astanza Laser LLC, Boss Laser LLc, Quantum Composers, Laser Photonics Corporation, Medioxra LLP.

Get the full plasmonic laser ablation device market report here:

Which Region Is Expected to Lead the Plasmonic Laser Ablation Device Market by 2029?
North America was the largest region in the plasmonic laser ablation device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasmonic laser ablation device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company


Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267



Follow Us On:

Comments

Post a Comment